Navigation Links
Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
Date:12/10/2013

NEW ORLEANS, Dec. 10, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced results of 40 clinical, non-clinical and pre-clinical presentations on ibrutinib (IMBRUVICA) at the 55TH Annual meeting of the American Society of Hematology (ASH) held in New Orleans, Dec 7 - 10, 2013. There were seven presentations of clinical data, of which five were oral presentations, including one "Best of ASH" presentation on Waldenstrom's macroglobulinemia (WM). In total, 33 additional pre-clinical and non-clinical presentations provided new discoveries using ibrutinib; seven of these were oral presentations. The presentations further elucidated the mechanism of action of ibrutinib and its effect in the tumor microenvironment and provided data on quality of life changes. Results covered various B-cell malignancies: chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), WM, and non-Hodgkin lymphoma (NHL).

"The breadth of data presented at ASH this year demonstrates the scientific community's interest in ibrutinib and builds on the clinical responses seen with ibrutinib as a backbone of combination therapy and as a single agent in multiple B-cell malignancies," said Jesse McGreivy, M.D., Chief Medical Officer, Pharmacyclics. "This year's data explain ibrutinib's effect on the quality of life for patients and build on impressive efficacy and safety results, independent of cytogenetic risk factors. We also now have long-term follow-up in CLL, which suggests continuation of the efficacy and a decrease in overall and severe adverse events."

Clinical Trial Presentation Highlights

Chronic Lymphocytic Leukemia

-POSTER PRESENTATION- Abstract #4163:
The Bruton's Tyrosine Kinase (BTK) Inhibitor Ibruti
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. Pharmacyclics Reports Third Quarter 2013 Results
3. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
4. Pharmacyclics Reports Second Quarter 2013 Results
5. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
6. Pharmacyclics Reports First Quarter 2013 Results
7. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
8. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
9. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
10. Pharmacyclics, Inc. Prices Public Offering of Common Stock
11. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... received a patent acceptance notice from the Israeli patent ... to prevent or reduce tissue damage caused by an ... when cardiac vessels are opened after a blockage causing ... stroke victims. Damage can be caused to ...
(Date:3/26/2015)... March 26, 2015 InfuSystem Holdings, Inc. (NYSE MKT: ... services for the healthcare industry in the United ... today it has secured a new $45.0 million credit facility ... $36.5 million credit facility with its prior lender group.  ... the new five-year senior secured credit agreement comprised of a ...
(Date:3/26/2015)... 2015  Oxis Biotech, Inc. (OXIS), a ... [OTC: OXIS] and [Euronext Paris: OXI.PA] announced ... agreement with the University of Pittsburgh related ... Xiang-Qun Xie , Associate Dean for ... of Pharmacy.  These patents/intellectual properties relate to ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3
... 2010 Omnicell, Inc ., (Nasdaq: ... to acute healthcare facilities, will display its latest innovations ... (ASHP) Midyear Clinical Meeting and Exhibition from December ... previewed include the new Omnicell Savvy™ mobile medication system; ...
... is natural that all customers using the services of online ... for them and getting their order within the shortest possible ... and well-taken. This site assures new and regular clients with ... security. It uses the most updated methods to make every ...
Cached Medicine Technology:Omnicell to Showcase Latest Product Innovations at ASHP 2Omnicell to Showcase Latest Product Innovations at ASHP 3Omnicell to Showcase Latest Product Innovations at ASHP 4Omnicell to Showcase Latest Product Innovations at ASHP 5A New Online Pharmacy rxbuys.com by RX Corp Offers its Services to International Clients 2
(Date:3/26/2015)... (PRWEB) March 26, 2015 Visiting ... celebrate their 18th annual gala fundraiser, Lighting the Way, ... 6:30 p.m. at The Madison Hotel in Morristown, NJ. ... live entertainment by renowned musician Rio Clemente, delightful cuisine, ... Pat and Dave Hertzel. Additionally, two prestigious awards will ...
(Date:3/26/2015)... Calif. (PRWEB) March 26, 2015 Pacific ... repairs, is pleased to be featured on Innovations with ... on March 18, 2015. The episode will repeat ... is live on the Pacific Medical home page at: ... life threatening emergencies, it is reassuring to trust the ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... the Patients’ Access to Treatments Act (PATA) that ... week by Reps. David B. McKinley (R-WV) and ... limit cost-sharing requirements for medications placed in a ... by reducing patients’ out-of-pocket expenses. , This legislation ...
(Date:3/26/2015)... March 26, 2015 Leading nutritional ... state-of-the-art company website: http://www.metabolicnutrition.com . The ... website creates a user-friendly experience for consumers seeking ... , The new, enhanced Metabolic Nutrition website includes: ... the company’s diverse line of products, conveniently broken ...
(Date:3/26/2015)... The beauty industry united on Saturday, March ... revolutionized the business of beauty education. The Beauty Changes ... Pivot Point International, Inc. Passage’s wife Lenie, and son ... at the Art Institute of Chicago, the sold-out event ... media leaders and served as the signature gala event ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... Queensland is leading the way on research into ... medical use. , The National Institute of ... Professor Luis Vitetta to establish a NICM Collaborative ... Nutraceuticals and Herbal Medicine, which aims to support ...
... The American Red Cross,today launched Red Cross Racing, a ... and raise awareness of the need to give blood. ... fans are now able to join the Donor Rewards ... donation appointments,online. The site also offers frequent donors the ...
... Study of the Liver ... Annual Meeting -, SAN ... for the Study of the Liver,(EASL), the positive results of a Phase ... conducted by Dr. Edward,Gane, Associate Professor of Medicine, New Zealand Liver Transplant ...
... UK-based Association for International Cancer Research this week announced ... Dr Joe Tiralongo to further develop a potential anti-cancer ... , The grant will enable the team to ... in living cells. , Research leader Dr Joe Tiralongo ...
... surgeons to adjust suture tension during bridging procedures, ... SNN ; LSE: SN) Endoscopy Division today announced the ... to attach rotator cuff tissue to,bone in the shoulder. ... of North America (AANA) Spring Meeting, which began,today in ...
... Tool Helps Hospitals Assure That Their Computerized,Prescribing Systems ... in a National Hospital Quality Survey, WASHINGTON, ... Hospital Survey, The Leapfrog Group becomes the,first health ... hospitals to be,certain that their computerized medication prescribing ...
Cached Medicine News:Health News:UQ leads the way on complementary medicine research 2Health News:American Red Cross Launches New Interactive Website to Connect NASCAR Fans With Blood Donations 2Health News:Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R) 2Health News:Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R) 3Health News:$450,000 sweetener in colon cancer battle 2Health News:Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair 2Health News:Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair 3Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 2Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 3Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: